Relypsa Inc (RLYP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RLYP | SUPN | TSHA | ||
| Company | Relypsa Inc | Supernus Pharm | Taysha Gene Therapies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 31.98 | 36.55 | 2.50 | ||
| High | 31.98 | 37.21 | 3.03 | ||
| Low | 31.98 | 36.31 | 2.49 | ||
| Last | 31.98 | 36.37 | 2.93 | ||
| Change | -0.01 | +0.15 | +0.46 | ||
| % Change | -0.03% | +0.41% | +18.62% | ||
| Volume | 107 | 50,074 | 3,895,854 | ||
| 20-Day Average Volume | 1,769,415 | 413,208 | 7,398,521 | ||
| Previous Close | 31.99 | 36.22 | 2.47 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.95 | 35.85 | 1.92 | ||
| 20-Day Raw Stochastic | 62.50% | 52.53% | 97.82% | ||
| 20-Day Relative Strength | 76.83% | 58.64% | 67.05% | ||
| Weighted Alpha | +3.30 | +36.58 | +22.43 | ||
| Today's Opinion | N/A | 100% Buy | 8% Sell | ||
| Previous Opinion | N/A | 100% Buy | 8% Sell | ||
| Last Month's Opinion | N/A | 88% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.06% since 08/25/16 | +3.69% since 11/18/24 | +31.14% since 11/18/24 | ||
| Low | 31.95 on 08/29/16 | 34.88 on 11/19/24 | 1.96 on 11/20/24 | ||
| High | 32.04 on 08/31/16 | 37.21 on 11/25/24 | 3.03 on 11/25/24 | ||
| 1-Month | |||||
| %Chg | +0.47% since 08/01/16 | +7.72% since 10/25/24 | +50.25% since 10/25/24 | ||
| Low | 31.83 on 08/02/16 | 33.43 on 11/05/24 | 1.19 on 11/05/24 | ||
| High | 32.04 on 08/31/16 | 39.37 on 11/05/24 | 3.03 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | +61.03% since 06/01/16 | +4.52% since 08/23/24 | +35.90% since 08/23/24 | ||
| Low | 15.73 on 06/27/16 | 29.50 on 09/11/24 | 1.19 on 11/05/24 | ||
| High | 32.12 on 07/27/16 | 39.37 on 11/05/24 | 3.03 on 11/25/24 | ||
| 6-Month | |||||
| %Chg | +137.59% since 03/01/16 | +32.86% since 05/24/24 | -7.72% since 05/24/24 | ||
| Low | 11.60 on 03/16/16 | 25.53 on 06/14/24 | 1.19 on 11/05/24 | ||
| High | 32.12 on 07/27/16 | 39.37 on 11/05/24 | 4.32 on 06/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,434,910 | 2,000,032 | 506,209 | ||
| Shares Outstanding, K | 44,840 | 55,219 | 204,943 | ||
| Annual Sales | 18,550,000 | 607,520,000 | 15,450,000 | ||
| Annual Net Income | -178,720,000 | 1,320,000 | -111,570,000 | ||
| Last Quarter Sales | 5,220,000 | 175,690,000 | 1,790,000 | ||
| Last Quarter Net Income | -83,620,000 | 38,500,000 | -25,520,000 | ||
| 60-Month Beta | 2.19 | 0.86 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 05/04/16 | 1.06 on 11/04/24 | -0.09 on 11/13/24 | ||
| Latest Earnings Date | 08/11/16 | 11/04/24 | 11/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.93 | 31.14 | ||